The effect of erythropoietin on autologous stem cell-mediated bone regeneration
- 1 October 2013
- journal article
- Published by Elsevier in Biomaterials
- Vol. 34 (30) , 7364-7371
Abstract
No abstract availableKeywords
Funding Information
- NIH (EB007271)
This publication has 63 references indexed in Scilit:
- Biomaterial implants mediate autologous stem cell recruitment in miceActa Biomaterialia, 2011
- Tissue Distribution of Mesenchymal Stem Cell Marker Stro-1Stem Cells and Development, 2011
- Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balanceProceedings of the National Academy of Sciences, 2010
- The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory responseBiomaterials, 2010
- Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to MitosisDevelopmental Cell, 2010
- Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelBone, 2008
- Endochondral bone tissue engineering using embryonic stem cellsProceedings of the National Academy of Sciences, 2008
- Structural Coupling of Smad and Runx2 for Execution of the BMP2 Osteogenic SignalJournal of Biological Chemistry, 2008
- Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol‐3 kinase and ERK1/2 activationBritish Journal of Pharmacology, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006